Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05484700

Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms

Long COVID-19 Clinical Trial

Official title:
SARS-CoV-2 Neutralizing Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Correlation With Immunity and Long-COVID-19 Symptoms

Clinical Trial Summary

We investigated the association between immune system responsibilities in Long COVID patients and Full recovery patients.

Clinical Trial Description

This retrospective cohort study compared immunogenicity post COVID-19 between individuals (aged 18-65 years and had confirmed SARS-CoV-2 infection from January to May 2022 ) with residual Long COVID-19 symptoms (LC) and ones with full recovery (Full) related to pathophysiology, immunology and clinical consequence. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05484700
Study type Observational
Source Mahidol University
Contact
Status Active, not recruiting
Phase
Start date December 30, 2021
Completion date December 29, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06073002 - Effects of a Home-Based Exercise Intervention in Subjects With Long COVID N/A
Enrolling by invitation NCT05965739 - RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms N/A
Enrolling by invitation NCT05965752 - RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms N/A
Recruiting NCT05747534 - AT1001 for the Treatment of Long COVID Phase 2
Recruiting NCT05817032 - Effect of Telerehabilitation Practice in Long COVID-19 Patients N/A
Enrolling by invitation NCT06305780 - RECOVER-AUTONOMIC Platform Protocol Phase 2
Enrolling by invitation NCT06305806 - RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine) Phase 2
Enrolling by invitation NCT06305793 - RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) Phase 2
Not yet recruiting NCT06404060 - RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance) N/A
Not yet recruiting NCT06404073 - RECOVER-ENERGIZE Platform Protocol_Appendix B (Structured Pacing (PEM)) N/A
Not yet recruiting NCT06404047 - RECOVER-ENERGIZE Platform Protocol N/A
Active, not recruiting NCT05813574 - Long Term Impact of COVID-19
Enrolling by invitation NCT05965726 - RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms Phase 2
Not yet recruiting NCT06404086 - RECOVER-SLEEP: Platform Protocol Phase 2
Not yet recruiting NCT06404099 - RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Phase 2
Not yet recruiting NCT06404112 - RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) Phase 2
Recruiting NCT05922865 - The Effect of Smart Sensor Combined With APP for Individualized Precise Exercise Training in Long Covid-19 N/A
Completed NCT04604704 - Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome Phase 2
Recruiting NCT05293366 - LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
Recruiting NCT05379556 - LOng COvid COmorbidities: Andrological, Reproductive, Sexual Dysfunctions in Patients Recovered From COVID-19